SYWISPO Trademark

Trademark Overview

On Friday, June 27, 2025, a trademark application was filed for SYWISPO with the United States Patent and Trademark Office. The USPTO has given the SYWISPO trademark a serial number of 99256146. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 26, 2025. This trademark is owned by Bristol-Myers Squibb Company. The SYWISPO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
sywispo

General Information

Serial Number99256146
Word MarkSYWISPO
Filing DateFriday, June 27, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 26, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events

Event DateEvent Description
Friday, June 27, 2025NEW APPLICATION ENTERED
Friday, June 27, 2025APPLICATION FILING RECEIPT MAILED
Friday, June 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 22, 2025ASSIGNED TO EXAMINER
Wednesday, August 20, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 26, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

sywispo diseases preparations purposes disease cancer medical treatment diagnostic solid radiopharmaceutical